• $45.00
    Market Cap
  • 0.00%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2022
12/31/2021
12/31/2020
Income Statement
Total Operating Revenue
1.0M
+139.07%
430,000
-35.63%
668,000
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
1.0M
+139.07%
430,000
-35.63%
668,000
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-1.4M
+47.90%
-975,000
-7.58%
-1.1M
N/A
Depreciation and Amortization Expense
15,000
-21.05%
19,000
+5.56%
18,000
N/A
Total Operating Expenses
2.8M
+33.32%
2.1M
-8.93%
2.3M
N/A
Operating Profit
-1.7M
-205.76%
1.6M
+202.10%
-1.6M
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-2.8M
+1.78%
-2.8M
+1.59%
-2.7M
N/A
Interest Income and Expense and Net
-2.8M
+1.78%
-2.8M
+1.59%
-2.7M
N/A
Total Nonoperating Income and Expense
260,000
-20.97%
329,000
+320.81%
-149,000
N/A
Income before Taxes
-4.8M
+1.59%
-4.7M
+14.44%
-4.1M
N/A
Income Taxes
0
N/A
0
-100.00%
25,000
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-4.8M
+1.59%
-4.7M
+13.76%
-4.2M
N/A
Net Income from Continuing Operations Applicable to Common
-4.8M
+1.59%
-4.7M
+14.44%
-4.1M
N/A
Basic EPS and Net Income
-0.02
0.00%
-0.02
+100.00%
-0.01
N/A
Diluted EPS and Net Income
-0.02
0.00%
-0.02
+100.00%
-0.01
N/A
Basic Weighted Average Shares
303.8B
+99,900.00%
303.8M
0.00%
303.8M
N/A
Diluted Weighted Average Shares
303.8B
+99,900.00%
303.8M
0.00%
303.8M
N/A
Balance Sheet
Cash and Cash Equivalents
313,000
-45.18%
571,000
-47.28%
1.1M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
313,000
-45.18%
571,000
-47.28%
1.1M
N/A
Total Current Assets
481,000
-28.53%
673,000
-45.68%
1.2M
N/A
Accumulated Depreciation
475,000
+0.42%
473,000
+2.16%
463,000
N/A
Property and Plant and Equipment and Net
26,000
-33.33%
39,000
-18.75%
48,000
N/A
Total Long-Term Assets
26,000
-33.33%
39,000
-18.75%
48,000
N/A
Total Assets
7.3M
-4.07%
7.6M
-5.73%
8.1M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
10.5M
-84.45%
67.3M
+6.62%
63.1M
N/A
Total Current Liabilities
72.0M
+6.83%
67.4M
+6.58%
63.3M
N/A
Total Long-Term Debt
156,000
-3.70%
162,000
+3.85%
156,000
N/A
Total Long-Term Liabilities
187,000
-35.96%
292,000
+59.56%
183,000
N/A
Total Liabilities
72.2M
+6.64%
67.7M
+6.73%
63.4M
N/A
Retained Earnings
-102.6M
+4.92%
-97.8M
+5.08%
-93.0M
N/A
Total Stockholders Equity
-64.9M
+8.01%
-60.1M
+8.55%
-55.4M
N/A
Total Shares Outstanding
303.8M
0.00%
303.8M
0.00%
303.8M
N/A
Cash Flow
Cash from Operating Activities
-1.7M
-0.65%
-1.7M
+0.12%
-1.7M
N/A
Capital Expenditures
2,000
-80.00%
10,000
-28.57%
14,000
N/A
Cash from Investing Activities
-2,000
-80.00%
-10,000
-28.57%
-14,000
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
1.4M
+19.67%
1.2M
-43.02%
2.1M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-169.75%
-144.24%
383.72%
+258.62%
-241.92%
N/A
Return on Assets
-64.27%
+6.85%
-60.15%
+14.12%
-52.71%
N/A
Return on Equity
7.69%
-6.17%
8.19%
+5.00%
7.80%
N/A
Revenue Growth
139.07%
+490.33%
-35.63%
-1,651.03%
2.30%
N/A
Current Ratio
0.007
-33.00%
0.01
-48.98%
0.02
N/A
Cash Ratio
0.004
-49.41%
0.009
-50.29%
0.02
N/A
Debt-to-Equity Ratio
-0.16
-85.42%
-1.12
-1.79%
-1.14
N/A
Debt-to-Assets Ratio
1.45
-83.59%
8.84
+13.10%
7.81
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow